消費者直販型ラボ検査のヨーロッパ市場2021年ー2031年:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Direct-to-Consumer Laboratory Testing Market (Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Chronic Disease Testing, COVID-19 Testing, TSH Testing, and Others; Sample Type: Blood, Saliva, Urine, and Others; and Provider: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Direct-to-Consumer Laboratory Testing Market (Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Chronic Disease Testing, COVID-19 Testing, TSH Testing, and Others; Sample Type: Blood, Saliva, Urine, and Others; and Provider: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031「消費者直販型ラボ検査のヨーロッパ市場2021年ー2031年:産業分析、規模、シェア、成長、動向、予測」(市場規模、市場予測)調査レポートです。• レポートコード:TMR2201B041
• 出版社/出版日:Transparency Market Research / 2021年11月15日
• レポート形態:英文、PDF、197ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥782,325 (USD5,795)▷ お問い合わせ
  Site Licence¥1,187,325 (USD8,795)▷ お問い合わせ
  Enterprisewide¥1,592,325 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、ヨーロッパの消費者直販型ラボ検査市場を調査・分析し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、キーインサイト、サンプル別分析、検査別分析、提供別分析、競争状況などを掲載しています。

Europe Direct-to-Consumer Laboratory Testing Market – Scope of Report
TMR’s report on the direct-to-consumer laboratory testing market in Europe studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the direct-to-consumer laboratory testing market in Europe for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the direct-to-consumer laboratory testing market in Europe for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the direct-to-consumer laboratory testing market in Europe.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the direct-to-consumer laboratory testing market in Europe.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the direct-to-consumer laboratory testing market in Europe. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the direct-to-consumer laboratory testing market in Europe. The next section of the direct-to-consumer laboratory testing market report highlights the USPs such as key industrial events (licensing partnership/merger & acquisition), disease epidemiology by region/country, COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact), and key success factors of top players operating in the direct-to-consumer laboratory testing market in Europe.

The report also delves into the competition landscape of the direct-to-consumer laboratory testing market in Europe. Key players operating in the direct-to-consumer laboratory testing market in Europe have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, strategic overview, and SWOT are some of the attributes of players in the direct-to-consumer laboratory testing market in Europe profiled in this report.

Key Questions Answered in Europe Direct-to-Consumer Laboratory Testing Market Report

What are the major drivers, restraints, and opportunities in the market?
What are the revenue share projections of key segments of the direct-to-consumer laboratory testing market in Europe during the forecast period?
Which segment is likely to lead the direct-to-consumer laboratory testing market in Europe in terms of revenue by 2031?
How technological developments are widening the scope for the direct-to-consumer laboratory testing market in Europe?
What is the market position of different companies operating in the direct-to-consumer laboratory testing market in in Europe?
Europe Direct-to-Consumer Laboratory Testing Market – Research Objectives and Research Approach

The comprehensive report on the direct-to-consumer laboratory testing market in Europe begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the direct-to-consumer laboratory testing market in Europe. It is followed by market introduction, market dynamics, and an overview of the direct-to-consumer laboratory testing market in Europe, which includes TMR analysis of market drivers, restraints, and opportunities affecting the growth of the direct-to-consumer laboratory testing market in Europe. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the direct-to-consumer laboratory testing market in Europe.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the direct-to-consumer laboratory testing market in in Europe in terms of test type, sample type, provider, and country. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the direct-to-consumer laboratory testing market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Europe Direct-to-Consumer Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)
5.2. Disease Prevalence & Incidence Rate
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type
7. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.1.1. Nutrigenetics Test
7.3.1.1.1. Weight Control
7.3.1.1.2. Lactose Intolerance
7.3.1.1.3. Others
7.3.1.2. Celiac Disease Test
7.3.1.3. Sports & Physical Activity Testing
7.3.1.4. Men’s Health Tests
7.3.1.5. Women’s Health Tests
7.3.1.6. Pregnancy & Prenatal Screening Test
7.3.1.7. General Health Testing
7.3.1.8. Others
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Sexual Health Tests
7.3.2.1.1. HIV
7.3.2.1.2. Chlamydia
7.3.2.1.3. Others
7.3.2.2. Cancer Predisposition Tests
7.3.2.3. Others
7.3.3. CBC
7.3.4. Chronic Disease Testing
7.3.4.1. Diabetes Testing
7.3.4.2. Hypertension
7.3.4.3. Others
7.3.5. COVID-19 Testing
7.3.6. TSH Testing
7.3.7. Others
7.4. Market Attractiveness Analysis, by Test Type
8. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Provider, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Speciality Labs
8.3.4. Diagnostic Centres
8.4. Market Attractiveness Analysis, by Provider
9. Germany Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Sample Type, 2017–2031
9.2.1. Blood
9.2.2. Urine
9.2.3. Saliva
9.2.4. Others
9.3. Market Value Forecast, by Test Type, 2017–2031
9.3.1. Genetic Testing
9.3.1.1. Nutrigenetics Test
9.3.1.1.1. Weight Control
9.3.1.1.2. Lactose Intolerance
9.3.1.1.3. Others
9.3.1.2. Celiac Disease Test
9.3.1.3. Sports & Physical Activity Testing
9.3.1.4. Men’s Health Tests
9.3.1.5. Women’s Health Tests
9.3.1.6. Pregnancy & Prenatal Screening Test
9.3.1.7. General Health Testing
9.3.1.8. Others
9.3.2. Disease Risk Assessment Testing
9.3.2.1. Sexual Health Tests
9.3.2.1.1. HIV
9.3.2.1.2. Chlamydia
9.3.2.1.3. Others
9.3.2.2. Cancer Predisposition Tests
9.3.2.3. Others
9.3.3. CBC
9.3.4. Chronic Disease Testing
9.3.4.1. Diabetes Testing
9.3.4.2. Hypertension
9.3.4.3. Others
9.3.5. COVID-19 Testing
9.3.6. TSH Testing
9.3.7. Others
9.4. Market Value Forecast, by Provider, 2017–2031
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Speciality Labs
9.4.4. Diagnostic Centres
10. U.K. Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Sample Type, 2017–2031
10.2.1. Blood
10.2.2. Urine
10.2.3. Saliva
10.2.4. Others
10.3. Market Value Forecast, by Test Type, 2017–2031
10.3.1. Genetic Testing
10.3.1.1. Nutrigenetics Test
10.3.1.1.1. Weight Control
10.3.1.1.2. Lactose Intolerance
10.3.1.1.3. Others
10.3.1.2. Celiac Disease Test
10.3.1.3. Sports & Physical Activity Testing
10.3.1.4. Men’s Health Tests
10.3.1.5. Women’s Health Tests
10.3.1.6. Pregnancy & Prenatal Screening Test
10.3.1.7. General Health Testing
10.3.1.8. Others
10.3.2. Disease Risk Assessment Testing
10.3.2.1. Sexual Health Tests
10.3.2.1.1. HIV
10.3.2.1.2. Chlamydia
10.3.2.1.3. Others
10.3.2.2. Cancer Predisposition Tests
10.3.2.3. Others
10.3.2.4. CBC
10.3.2.5. Chronic Disease Testing
10.3.2.5.1. Diabetes Testing
10.3.2.5.2. Hypertension
10.3.2.5.3. Others
10.3.2.6. COVID-110 Testing
10.3.2.7. TSH Testing
10.3.2.8. Others
10.4. Market Value Forecast, by Provider, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Speciality Labs
10.4.4. Diagnostic Centres
11. France Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Sample Type, 2017–2031
11.2.1. Blood
11.2.2. Urine
11.2.3. Saliva
11.2.4. Others
11.3. Market Value Forecast, by Test Type, 2017–2031
11.3.1. Genetic Testing
11.3.1.1. Nutrigenetics Test
11.3.1.1.1. Weight Control
11.3.1.1.2. Lactose Intolerance
11.3.1.1.3. Others
11.3.1.2. Celiac Disease Test
11.3.1.3. Sports & Physical Activity Testing
11.3.1.4. Men’s Health Tests
11.3.1.5. Women’s Health Tests
11.3.1.6. Pregnancy & Prenatal Screening Test
11.3.1.7. General Health Testing
11.3.1.8. Others
11.3.2. Disease Risk Assessment Testing
11.3.2.1. Sexual Health Tests
11.3.2.1.1. HIV
11.3.2.1.2. Chlamydia
11.3.2.1.3. Others
11.3.2.2. Cancer Predisposition Tests
11.3.2.3. Others
11.3.3. CBC
11.3.4. Chronic Disease Testing
11.3.4.1. Diabetes Testing
11.3.4.2. Hypertension
11.3.4.3. Others
11.3.5. COVID-19 Testing
11.3.6. TSH Testing
11.3.7. Others
11.4. Market Value Forecast, by Provider, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Speciality Labs
11.4.4. Diagnostic Centres
12. Italy Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Sample Type, 2017–2031
12.2.1. Blood
12.2.2. Urine
12.2.3. Saliva
12.2.4. Others
12.3. Market Value Forecast, by Test Type, 2017–2031
12.3.1. Genetic Testing
12.3.1.1. Nutrigenetics Test
12.3.1.1.1. Weight Control
12.3.1.1.2. Lactose Intolerance
12.3.1.1.3. Others
12.3.1.2. Celiac Disease Test
12.3.1.3. Sports & Physical Activity Testing
12.3.1.4. Men’s Health Tests
12.3.1.5. Women’s Health Tests
12.3.1.6. Pregnancy & Prenatal Screening Test
12.3.1.7. General Health Testing
12.3.1.8. Others
12.3.2. Disease Risk Assessment Testing
12.3.2.1. Sexual Health Tests
12.3.2.1.1. HIV
12.3.2.1.2. Chlamydia
12.3.2.1.3. Others
12.3.2.2. Cancer Predisposition Tests
12.3.2.3. Others
12.3.3. CBC
12.3.4. Chronic Disease Testing
12.3.4.1. Diabetes Testing
12.3.4.2. Hypertension
12.3.4.3. Others
12.3.5. COVID-19 Testing
12.3.6. TSH Testing
12.3.7. Others
12.4. Market Value Forecast, by Provider, 2017–2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Speciality Labs
12.4.4. Diagnostic Centres
13. Spain Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Sample Type, 2017–2031
13.2.1. Blood
13.2.2. Urine
13.2.3. Saliva
13.2.4. Others
13.3. Market Value Forecast, by Test Type, 2017–2031
13.3.1. Genetic Testing
13.3.1.1. Nutrigenetics Test
13.3.1.1.1. Weight Control
13.3.1.1.2. Lactose Intolerance
13.3.1.1.3. Others
13.3.1.2. Celiac Disease Test
13.3.1.3. Sports & Physical Activity Testing
13.3.1.4. Men’s Health Tests
13.3.1.5. Women’s Health Tests
13.3.1.6. Pregnancy & Prenatal Screening Test
13.3.1.7. General Health Testing
13.3.1.8. Others
13.3.2. Disease Risk Assessment Testing
13.3.2.1. Sexual Health Tests
13.3.2.1.1. HIV
13.3.2.1.2. Chlamydia
13.3.2.1.3. Others
13.3.2.2. Cancer Predisposition Tests
13.3.2.3. Others
13.3.3. CBC
13.3.4. Chronic Disease Testing
13.3.4.1. Diabetes Testing
13.3.4.2. Hypertension
13.3.4.3. Others
13.3.5. COVID-19 Testing
13.3.6. TSH Testing
13.3.7. Others
13.4. Market Value Forecast, by Provider, 2017–2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Speciality Labs
13.4.4. Diagnostic Centres
14. Rest of Europe Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Sample Type, 2017–2031
14.2.1. Blood
14.2.2. Urine
14.2.3. Saliva
14.2.4. Others
14.3. Market Value Forecast, by Test Type, 2017–2031
14.3.1. Genetic Testing
14.3.1.1. Nutrigenetics Test
14.3.1.1.1. Weight Control
14.3.1.1.2. Lactose Intolerance
14.3.1.1.3. Others
14.3.1.2. Celiac Disease Test
14.3.1.3. Sports & Physical Activity Testing
14.3.1.4. Men’s Health Tests
14.3.1.5. Women’s Health Tests
14.3.1.6. Pregnancy & Prenatal Screening Test
14.3.1.7. General Health Testing
14.3.1.8. Others
14.3.2. Disease Risk Assessment Testing
14.3.2.1. Sexual Health Tests
14.3.2.1.1. HIV
14.3.2.1.2. Chlamydia
14.3.2.1.3. Others
14.3.2.2. Cancer Predisposition Tests
14.3.2.3. Others
14.3.3. CBC
14.3.4. Chronic Disease Testing
14.3.4.1. Diabetes Testing
14.3.4.2. Hypertension
14.3.4.3. Others
14.3.5. COVID-19 Testing
14.3.6. TSH Testing
14.3.7. Others
14.4. Market Value Forecast, by Provider, 2017–2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Speciality Labs
14.4.4. Diagnostic Centres
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. 23andMe, Inc.
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Ancestry
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. SWOT Analysis
15.2.3. CircleDNA
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. SWOT Analysis
15.2.4. Eurofins Scientific
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.5. Family Tree DNA (Gene by Gene)
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. SWOT Analysis
15.2.6. Laboratory Corporation of America Holdings
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Living DNA Ltd.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. SWOT Analysis
15.2.8. Medichecks.com Ltd.
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. SWOT Analysis
15.2.9. MyHeritage Ltd.
15.2.9.1. Company Description
15.2.9.2. Business Overview
15.2.9.3. SWOT Analysis
15.2.10. MyMedLab, Inc.
15.2.10.1. Company Description
15.2.10.2. Business Overview
15.2.10.3. SWOT Analysis
15.2.11. Quest Diagnostics Incorporated
15.2.11.1. Company Description
15.2.11.2. Business Overview
15.2.11.3. Financial Overview
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis

List of Tables

Table 01: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 07: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 08: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 09: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 10: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 12: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 13: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 14: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 15: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 16: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 17: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 18: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 20: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 21: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 22: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 23: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 24: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 25: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 26: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 27: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 28: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 29: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 30: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 31: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 32: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 33: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 34: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 35: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 36: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 37: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 38: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 39: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 40: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 41: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 42: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 43: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 44: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 45: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 46: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 47: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 48: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 49: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 50: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 51: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 52: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 53: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 54: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 55: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 56: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031


• 英文レポート名:Direct-to-Consumer Laboratory Testing Market (Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Chronic Disease Testing, COVID-19 Testing, TSH Testing, and Others; Sample Type: Blood, Saliva, Urine, and Others; and Provider: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
• 日本語訳:消費者直販型ラボ検査のヨーロッパ市場2021年ー2031年:産業分析、規模、シェア、成長、動向、予測
• レポートコード:TMR2201B041お問い合わせ(見積依頼・ご注文・質問)